COMMUNIQUÉS West-GlobeNewswire

Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System
09/08/2025
Covering both mosquito-borne diseases and emerging respiratory pathogens, Anbio continues to advance point-of-care diagnostics for timely outbreak detection worldwide. FRANKFURT, Germany, Aug. 08, 2025 (GLOBE NEWSWIRE [...]
NurExone’s Exosomes Show Stronger Healing Potential Than Industry Standard
08/08/2025
Independent Study and Bioanalysis Suggests More Effective Nerve Repair and Faster Wound Healing TORONTO and HAIFA, Israel, Aug. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90 [...]
Heartland Physio Unveils The R.E.A.L. Recovery Experience for Singapore’s Active Professionals
08/08/2025
A personalised, root-cause approach that challenges one-size-fits-all physiotherapy. Singapore, Singapore, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Heartland Physio is proud to unveil its signature R.E.A.L. Recovery™ [...]
Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025
08/08/2025
Company to host an investor conference call and webcast at 4:30 pm ET NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Hyperion Defi , Inc. (NASDAQ: HYPD), the first U.S. public company to build a strategic treasury around [...]
Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates
08/08/2025
F DA provides pivotal agreement on EB613 Phase 3 design, confirming B one M ineral D ensity (BMD) as primary endpoint and clearing streamlined pathway for first oral anabolic osteoporosis treatment Significant [...]
Amwell makes grant to new employees under inducement plan
08/08/2025
BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading technology-enabled care platform provider, announces that on August 8, Amwell made grants of RSUs covering an aggregate of 76,198 shares of its [...]
Femasys Announces Second Quarter Financial Results for 2025
08/08/2025
-- Continued Progress on Regulatory Approvals and Global Commercialization of Fertility Portfolio -- ATLANTA, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making [...]
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/08/2025
BRISBANE, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on August 4, 2025, the Compensation Committee of Vera’s Board of Directors granted inducement awards [...]
Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
08/08/2025
– Filing based on pivotal Phase 3 VERITAC-2 clinical trial demonstrating statistically significant and clinically meaningful improvement in median progression-free survival versus fulvestrant – – Vepdegestrant is the [...]
Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update
08/08/2025
Daniel Chao, M.D., Ph.D., joins Surrozen as Vice President of Clinical Development Surrozen forms Clinical Advisory Board comprised of leading retinal specialists Data Presentations at Association for Research in Vision [...]
Nyxoah Obtient l'Autorisation de la FDA pour le Système Genio® Destiné au Traitement de l'Apnée Obstructive du Sommeil
08/08/2025
INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Nyxoah Obtient l'Autorisation de la FDA pour le Système Genio® Destiné au Traitement de l'Apnée Obstructive du Sommeil Lancement Officiel de la Commercialisation aux [...]
Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea
08/08/2025
INSIDE INFORMATION REGULATED INFORMATION Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea U.S. Commercialization Officially Launched Mont-Saint-Guibert, Belgium – August 8 [...]
Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights
08/08/2025
Presented preclinical data at the American Society of Clinical Oncology (ASCO) on CLD-401 demonstrating biological efficacy IL-15 superagonist delivery to metastatic tumor sites and reduced immune clearance through [...]
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/08/2025
CAMBRIDGE, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with [...]
Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results
08/08/2025
TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported [...]
Earth Science Tech, Inc. Reports 61% Asset Growth to $7.69 Million and $8.7 Million in First Quarter Revenue Following Foundational Quarter of Strategic Acquisitions
08/08/2025
MIAMI, FL, Aug. 08, 2025 (GLOBE NEWSWIRE) -- MIAMI, FL – August 8, 2025 – Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential [...]
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/08/2025
MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants
08/08/2025
MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it has entered into a [...]
Aja Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements and Implementation of Cease Trade Order
09/08/2025
Not for dissemination in the United States of America VANCOUVER, British Columbia, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that the Alberta Securities [...]

Pages